F.M. Djuraev

Работ: 8

Oncology Tashkent Medical Park, Tashkent, Uzbekistan

28P One-week ultra-hypofractionated partial breast RT in early breast cancer: 3DCRT vs IMRT
N.O. Zaynutdinov, A.S. Abdujapparov, F.M. Djuraev +1
СтатьяMedical Imaging Techniques and ApplicationsAnnals of Oncology2023Цитирований: 0
ABI
10P Neoadjuvant chemotherapy with bevacizumab for IIb stage cervical cancer: Is it time to rethink standard of care?
F.M. Djuraev, A.S. Abdujapparov
СтатьяEndometrial and Cervical Cancer TreatmentsESMO Open2023Цитирований: 0
ABI
35P Beyond microsatellite testing: Tumor mutational burden, should it be routine in patients with GI cancers?
F.M. Djuraev, A.S. Abdujapparov
СтатьяGenetic factors in colorectal cancerESMO Open2024Цитирований: 0
ABI
30P Cemiplimab in treatment of metastatic and recurrent cervical cancer
F.M. Djuraev, A.S. Abdujapparov
СтатьяCancer Immunotherapy and BiomarkersESMO Open2024Цитирований: 0
ABI
19P Adjuvant chemotherapy in colon cancer: 6 months better than 3?
Z. Alisher, F.M. Djuraev, A.S. Abdujapparov
СтатьяColorectal Cancer Surgical TreatmentsAnnals of Oncology2024Цитирований: 0
ABI
265P Is it time to change standard care for dMMR locally advanced rectal cancer?
A.S. Abdujapparov, F.M. Djuraev
СтатьяColorectal Cancer Surgical TreatmentsAnnals of Oncology2024Цитирований: 0
ABI
IUC23223-77 Triplet therapy in metastatic hormone-sensitive prostate cancer in Asian patients
Alexey R. Zakirov, F.M. Djuraev, O Raxmonov +1
СтатьяProstate Cancer Treatment and ResearchThe Oncologist2025Цитирований: 0
ABI
63P Combination of pembrolizumab lenvatinib in treatment of advanced hepatocellular carcinoma
Z. Alisher, F.M. Djuraev
СтатьяHepatocellular Carcinoma Treatment and PrognosisESMO Open2026Цитирований: 0
ABI